
|Articles|March 10, 2008
Clinical twisters: Addressing CVA prophylaxis
This case study assesses the need for anticoagulation and the drugs of choice for prophylaxis against cerebrovascular accidents (strokes) in patients with previous CVAs of different origins.
Advertisement
Nancy L. Shapiro, Pharm.D., BCPSAimee Chevalier, Pharm.D.
Clinical Pharmacists, Antithrombosis Clinic
Clinical Assistant Professor, Dept. of Pharmacy Practice
University of Illinois at Chicago College of Pharmacy
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
Vaccine Policy in Flux: Stories Pharmacists Need to Follow
3
Pharmacists Want Prescribing Authority With Proper Training, Support
4
Q&A: Pharmacists Help Patients Navigate Pneumococcal Vaccine Options
5






























